Living with IBD: Targeted nutrition via digital platforms may improve disease activity and quality of life.

Background & Rationale

Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic inflammatory condition of the gastrointestinal tract. Nutritional support is recognised as an integral component of IBD management, but traditional dietary counselling is often limited by accessibility and adherence. Digital health tools, including mobile applications and online platforms, offer a potential solution to overcome these barriers, providing personalised nutritional guidance and ongoing support. This study investigated the effectiveness of a digital nutritional intervention designed to support standard IBD treatment, focusing on disease activity and patient-reported outcomes. The researchers hypothesised that utilising new digital technologies to deliver nutritional support could enhance clinical outcomes in IBD patients.

Study Design

This was a single-centre, prospective, randomised controlled trial. One hundred and two patients with IBD were randomised in a 1:1 ratio to either the intervention group or a standard care control group. The intervention consisted of a six-month digital nutritional programme delivered via a mobile application and web platform. The application offered personalised dietary recommendations based on individual disease characteristics and preferences, alongside weekly monitoring by a registered dietitian. The control group received standard dietary advice from their gastroenterologist. The primary outcome measure was the change in Crohn’s Disease Activity Index (CDAI) or Simple Clinical Colitis Activity Index (SCCAI) scores at six months. Secondary outcomes included changes in disease-specific quality of life, assessed using the Inflammatory Bowel Disease Questionnaire (IBDQ), and nutritional status.

Patient Population

A total of 102 patients with confirmed Crohn’s disease or ulcerative colitis participated in the study. The mean age of participants was 41.3 years, with 52% being female. Fifty-one patients were randomised to the intervention group and 51 to the control group. Sixty-four patients had Crohn’s disease and 38 had ulcerative colitis. The median disease duration was 7.2 years. At baseline, participants in both groups exhibited comparable disease activity scores, IBDQ scores and nutritional parameters. All patients were under standard pharmacological management for their IBD at the time of recruitment.

Key Findings

At six months, the intervention group exhibited a greater reduction in CDAI/SCCAI scores compared to the control group. The intervention group showed a mean reduction of 8.7 points, while the control group’s mean reduction was 2.3 points. The intervention group also demonstrated a statistically significant improvement in IBDQ scores, with a mean increase of 17.2 points, compared to an increase of 4.8 points in the control group. Assessments of nutritional status revealed improvements in several parameters in the intervention group, including serum albumin levels which rose by an average of 0.2 g/dL compared to an average of 0.05 g/dL in the control group. The proportion of patients achieving clinical remission was higher in the intervention group at 37.3% compared to 15.7% in the control group.

Discussion

The results suggest that a digitally delivered, personalised nutritional intervention can yield clinically meaningful improvements in IBD management, augmenting standard medical therapy. The observed reductions in disease activity scores and improvements in quality of life are noteworthy. The positive impact on nutritional parameters, such as albumin levels, suggests that the intervention addressed nutritional deficiencies frequently observed in IBD. The intervention demonstrated a good level of adherence, as evidenced by consistent engagement with the digital platform throughout the six-month study duration. The study reported that 94% of patients in the intervention group accessed the platform at least once per week. Adverse events attributed to the nutritional intervention were infrequent and mild, primarily consisting of transient gastrointestinal symptoms in a small percentage of patients.

Authors’ Conclusions

The authors concluded that “digital nutritional intervention, along with standard treatment, proved to be a useful strategy for improving IBD outcomes, demonstrating positive effects on disease activity, quality of life and nutritional status”. They suggest that digital tools can address limitations of traditional dietary counselling and facilitate personalised nutritional care for individuals with IBD. Further research is warranted to evaluate the long-term efficacy and cost-effectiveness of such interventions.

Reference

Suárez Ferrer C, Martorell Mariné I, Rueda García JL, Cubillo García C, García Ramírez L, Amiama Roig C, Sánchez Azofra M, Poza Cordon J, Martin Arranz E, García-Rojas Pleite C, Noci Belda J, Martin-Arranz MD. Usefulness of Nutritional Intervention Through New Digital Technologies in Patients with Inflammatory Bowel Disease. Nutrients. 2024;18(6):910. DOI: 10.3390/nu18060910.